If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 172.40
Bid: 172.20
Ask: 173.00
Change: -1.00 (-0.58%)
Spread: 0.80 (0.465%)
Open: 172.20
High: 174.00
Low: 172.00
Prev. Close: 173.40
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2023 Trading Update

24 Jan 2024 07:00

RNS Number : 6815A
Forterra plc
24 January 2024
 

24 January 2024

FORTERRA PLC

 

2023 Trading Update

 

Adjusted EBITDA expected to be slightly ahead of the Board's previous expectations

 

Forterra plc (the 'Group'), a leading UK manufacturer of essential clay and concrete building products, provides its trading update for the year ended 31 December 2023.

 

Trading

 

· Full year revenue totalled c.£345m (2022: £455m), a year-on-year reduction of c.24%, with the impact of falling sales volumes partially offset by pricing benefits.

 

· Despite weak demand, pricing across our range of products remains resilient with modest 2024 price increases recently communicated.

 

· Figures published by the Department of Business and Trade highlight that UK brick despatches in the three-month period to November were 33% lower than the equivalent period in 2022, taking the cumulative YTD reduction to approximately 30%. As highlighted previously, our own despatches fell by a greater percentage driven by our exposure to volume housebuilding which suffered the greatest impact from rising interest rates.

 

· Despite continued challenging market conditions we expect to report full year adjusted EBITDA slightly ahead of the Board's expectations.

 

Management Actions

 

· Strong management actions during the year will deliver annualised fixed costs savings in excess of £20m with around £6m realised in 2023 with the balance in 2024. One-off cash restructuring costs are expected to total £9m of which £4m will be paid in 2024.

 

· Faced with increasing inventory levels, we made further reductions to production during the second half of 2023 which, assuming 2024 demand remains consistent with 2023, will ensure output is aligned with sales.

 

· Production has been reduced through the mothballing of factories, shift reductions and production breaks. In addition, we have delivered further savings through restructuring commercial and back-office functions.

 

· These temporary reductions will not impact our ability to respond quickly when our markets recover, with the new Desford brick factory also providing us with a significant capacity uplift.

 

Balance Sheet

 

· Reflecting our inventory build, capital expenditure and the management actions taken during 2023, year-end net debt before leases is expected to be c.£95m.

 

Outlook

 

· The outlook for our industry remains subject to considerable uncertainty and, with a general election expected in 2024, demand is anticipated to remain subdued in the near term.

 

· However, with the long term under supply of housing in the UK continuing to worsen, and UK brick despatches now running at levels last seen in 2009, the Board remains confident in the Group's ability to benefit as our key markets recover.

 

· Recent reductions in mortgage interest rates will improve the affordability of new homes, thus increasing demand for our products.

 

· The Group intends to announce its FY23 results on 26 March 2024.

 

 

ENQUIRIES

 

 

Forterra plc

+44 1604 707 600

Neil Ash, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

FTI Consulting

+44 203 727 1340

Richard Mountain / Nick Hasell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUOVWRSWUAUAR
Date   Source Headline
10th Dec 20197:00 amRNSBoard Changes
6th Dec 201910:46 amRNSDirector/PDMR Shareholding
4th Dec 201912:01 pmRNSEmployee Benefit Trust Share Purchase
3rd Dec 20197:00 amRNSDirector/PDMR Shareholding
5th Nov 201912:38 pmRNSEmployee Benefit Trust Share Purchase
24th Oct 20199:51 amRNSHolding(s) in Company
22nd Oct 20197:00 amRNSTrading update
7th Oct 20192:03 pmRNSHolding(s) in Company
4th Oct 20192:09 pmRNSGrant of Options under 2018 SAYE Scheme
2nd Oct 20193:15 pmRNSEmployee Benefit Trust Share Purchase
26th Sep 20194:50 pmRNSEmployee Benefit Trust Share Purchase
9th Sep 20195:34 pmRNSDirector/PDMR Shareholding
4th Sep 20198:51 amRNSHolding(s) in Company
30th Jul 20197:00 amRNS2019 HALF YEAR RESULTS
4th Jul 201911:49 amRNSEmployee Benefit Trust Share Purchase
5th Jun 20199:20 amRNSEmployee Benefit Trust Share Purchase
20th May 20191:57 pmRNSResult of AGM
20th May 20197:00 amRNSAGM Trading Update
10th May 20193:08 pmRNSDirector/PDMR Shareholding
3rd May 20199:00 amRNSEmployee Benefit Trust Share Purchase
5th Apr 20192:50 pmRNSDirector/PDMR Shareholding
5th Apr 20192:49 pmRNSEmployee Benefit Trust Share Purchase
5th Apr 20191:21 pmRNSAnnual Report & Accounts 2018 and Notice of AGM
2nd Apr 20193:58 pmRNSDirector/PDMR Shareholding
29th Mar 20199:11 amRNSGrant under Performance Share Plan
29th Mar 20199:10 amRNSGrant under Deferred Annual Bonus Plan
14th Mar 201911:28 amRNSEmployee Benefit Trust Share Purchase
12th Mar 201910:00 amRNSEmployee Benefit Trust Share Purchase
5th Mar 20198:45 amRNSEmployee Benefit Trust Share Purchase
8th Feb 20199:00 amRNSDirector Declaration
8th Feb 20197:00 amRNSAppointment of new Independent NED
6th Feb 20191:30 pmRNSEmployee Benefit Trust Share Purchase
15th Jan 20191:38 pmRNSEmployee Benefit Trust Share Purchase
15th Jan 20197:00 amRNSTrading Update
8th Jan 20199:27 amRNSEmployee Benefit Trust Share Purchase
19th Dec 201810:09 amRNSEmployee Benefit Trust Share Purchase
4th Dec 20182:27 pmRNSEmployee Benefit Trust Share Purchase
27th Nov 201812:23 pmRNSHolding(s) in Company
20th Nov 201810:30 amRNSReplacement Director/PDMR Shareholding
20th Nov 20189:12 amRNSDirector/PDMR Shareholding
19th Nov 20181:30 pmRNSDirector/PDMR Shareholding
6th Nov 20188:55 amRNSEmployee Benefit Trust Share Purchase
1st Nov 20187:00 amRNSTrading Update
17th Oct 20188:49 amRNSHolding(s) in Company
16th Oct 20182:51 pmRNSHolding(s) in Company
9th Oct 20189:34 amRNSDirector Declaration
5th Oct 20182:07 pmRNSEmployee Benefit Trust Share Purchase
4th Oct 20188:58 amRNSGrant of Options under 2018 SAYE Scheme
27th Sep 20181:37 pmRNSHolding(s) in Company
18th Sep 20184:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.